Single and Multiple Ascending Dose Study of TD-8236 by Inhalation
Clinical trial NCT03652038 · COMPLETED
Trial details
- NCT number
- NCT03652038
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2020-07-13
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.